The podcast explores the potential of creatine monohydrate as a treatment for depression and mood disorders, diverging from its conventional use in sports for enhancing strength. The panel reviews multiple studies, including one indicating that creatine, when combined with cognitive behavioral therapy, leads to significant reductions in PHQ-9 scores, a measure of depression severity. They discuss optimal creatine dosage, suggesting that higher doses (10 grams or more) may be more effective for brain function than the standard five grams. The panel also examines creatine's mechanism, highlighting its role in regenerating ATP for brain cells during high-energy demands, such as sleep deprivation. The discussion addresses safety, with experts agreeing that creatine is generally safe, though kidney function should be monitored, and they emphasize the need for more extensive, well-funded research.
Sign in to continue reading, translating and more.
Continue